10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001104659-16-155185`
Period End Date	20160930
Filing Date	20161107
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	cldx-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 61 Cash Flow Statement 56

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.74M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$66.79M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$171.50M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$217.78M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$970.00K	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.58M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.89M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.08M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$209.71M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	98.69M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$294.94M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	101.25M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	98.69M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	101.25M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$11.46M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$11.36M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$20.79M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$20.03M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.88M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.43M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$251.95M	USD	Point-in-time
Total Assets	`Assets`	$337.58M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.51M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.02M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$13.23M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$24.32M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.38M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.42M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$30.24M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$18.63M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$17.24M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$16.23M	USD	Point-in-time
Total Liabilities	`Liabilities`	$34.85M	USD	Point-in-time
Total Liabilities	`Liabilities`	$47.48M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 101,248,821 and 98,685,595 Shares Issued and Outstanding at September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$99.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 101,248,821 and 98,685,595 Shares Issued and Outstanding at September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$101.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$878.65M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$901.56M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.61M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.31M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-590.96M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-687.18M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$217.09M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$290.11M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$337.58M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$251.95M	USD	Point-in-time

Income Statement 61 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.55M	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$493.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.05M	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$377.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$649.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$3.36M	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.73M	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$2.64M	USD	3 Qtrs
Total Revenue	`Revenues`	$2.22M	USD	1 Quarter
Total Revenue	`Revenues`	$1.03M	USD	1 Quarter
Total Revenue	`Revenues`	$4.91M	USD	3 Qtrs
Total Revenue	`Revenues`	$3.69M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$76.27M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$25.01M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$24.66M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$78.17M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$8.49M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$24.05M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$22.76M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$6.95M	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$99.79M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$102.98M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$32.21M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$33.40M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-98.06M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-29.99M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-96.10M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-32.37M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.59M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.84M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$395.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$391.00K	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.60M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-96.22M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.98M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-94.51M	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share) (Note 3)	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share) (Note 3)	`EarningsPerShareBasicAndDiluted`	$-0.97	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share) (Note 3)	`EarningsPerShareBasicAndDiluted`	$-0.98	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share) (Note 3)	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares) (Note 3)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	96.52M	shares	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares) (Note 3)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	100.67M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares) (Note 3)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.57M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares) (Note 3)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	99.40M	shares	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.60M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-96.22M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.98M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-94.51M	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$15.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$124.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-45.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-113.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$303.00K	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-95.92M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-94.54M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-31.86M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-29.71M	USD	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.60M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-96.22M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.98M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-94.51M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.15M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.13M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-768.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$501.00K	USD	3 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-74.00K	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$11.71M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$8.68M	USD	3 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$216.00K	USD	3 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$1.64M	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$100.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$609.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$478.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$325.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-6.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-70.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-11.56M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.29M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.05M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-85.14M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-92.69M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$129.35M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$194.91M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$149.88M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$193.81M	USD	3 Qtrs
Investment in Other	`PaymentsToAcquireOtherInvestments`	$1.80M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.11M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.47M	USD	3 Qtrs
Net Cash Provided by (Used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-68.94M	USD	3 Qtrs
Net Cash Provided by (Used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$41.12M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$188.84M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$10.67M	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$3.99M	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$532.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$192.83M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$11.20M	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$15.00K	USD	3 Qtrs
Net (Decrease) Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$38.77M	USD	3 Qtrs
Net (Decrease) Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-40.37M	USD	3 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$31.74M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$66.79M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$31.74M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$66.79M	USD	Point-in-time
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$38.00K	USD	3 Qtrs
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$65.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.